ArticleBMC nephrology2026
Relationship between urine output and 28-day mortality in patients with acute kidney injury receiving continuous renal replacement therapy.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Lower versus standard dose-intensity continuous renal replacement therapy: a systematic review and meta-analysis.Critical care (London, England) · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundMost critically ill patients with acute kidney injury (AKI) can be controlled with continuous renal replacement therapy (CRRT), but the timing of CRRT initiation is debatable and there is no specific indication. The aim of this study was to investigate whether there is a correlation between different urine output levels at the start of CRRT and the prognosis of critically ill patients with AKI who require CRRT.
methodsThis was a secondary analysis that retrieved the clinical, biochemical, and 28-day mortality rates of critically ill AKI patients who required CRRT from 2009 to 2016, and grouped the patients into two groups of patients with 2-hour urine output at the start of CRRT, and explored the effect of urine output at the onset of CRRT on 28-day all-cause mortality through univariate, multivariate, Kaplan-Meier curves, and subgroup analyses.
resultsA total of 1138 participants were enrolled in this study. Multivariate Cox proportional hazards regression analysis showed a significantly lower 28-day risk of death in the non-oliguria group compared with the oliguria group after fully adjusting for confounding variables (P = 0.0014), with an adjusted hazard ratio (95% confidence interval) of 0.75 (0.63–0.89). Subgroup analyses showed that oliguria and an increased risk of 28-day mortality were associated in patients requiring CRRT due to hyperkalemia and AKI due to sepsis, but this result was not found in patients with other indications for CRRT and other causes of AKI.
conclusionOliguria is associated with an increased risk of 28-day mortality in critically ill AKI patients requiring CRRT, especially in patients requiring CRRT due to hyperkalemia, and in patients with AKI due to sepsis. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.